JBIO compared with ELVN: revenue, margins and what each company keeps, and the suppliers and customers both name

JBIOJade Biosciences, Inc.

Mkt capRevenueRevenue

ELVNEnliven Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

JBIOJade Biosciences, Inc.

ELVNEnliven Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only JBIO 3

—Patheon Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

—WuXi Biologics Irelandunlistedsupplier

Shared 0

No shared counterparties.

Only ELVN 5

—CoreRxunlistedsupplier

—Hande Sciencesunlistedsupplier

—Latitude Pharmaceuticalsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Pharmaron

unlistedsupplier

1 more · ELVN chain ›

JBIOJade Biosciences, Inc.

14.07· pre 14.07· delayed

Mkt cap$894.2M

ELVNEnliven Therapeutics, Inc.

44.25· pre 44.25· delayed

Pre-marketOct 30 '26delayed

Mkt cap$3.2B

Compare

Pre-marketOct 30 '26delayed

JBIOJade Biosciences, Inc.

ELVNEnliven Therapeutics, Inc.

14.07pre 14.07delayed

Price

44.25pre 44.25delayed

$894.2M

Mkt cap

$3.2B

JBIO14.07vsELVN44.25Pre-marketOct 30 '26delayed